Share This Author
Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians.
- A. Fagiolini, E. Frank, John Scott, Scott R. Turkin, D. Kupfer
- MedicineBipolar disorders
- 1 October 2005
The prevalence of the metabolic syndrome in patients with bipolar disorder is alarmingly high, as it is for the general population, and the findings are a reason for concern, considering the difficulty in implementing prevention and treatment programs in the bipolar population.
Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder.
Interpersonal and social rhythm therapy appears to add to the clinical armamentarium for the management of bipolar I disorder, particularly with respect to prophylaxis of new episodes.
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia.
Several suggestive, novel associations were detected with circadian genes and BPI and SZ/SZA, but the present analyses do not support associations with common polymorphisms that confer risk with odds ratios greater than 1.5.
Obesity as a correlate of outcome in patients with bipolar I disorder.
- A. Fagiolini, D. Kupfer, P. Houck, D. Novick, E. Frank
- Medicine, PsychologyThe American journal of psychiatry
Preventing and treating obesity in bipolar disorder patients could decrease the morbidity and mortality related to physical illness, enhance psychological well-being, and possibly improve the course of bipolar illness.
The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach.
The presence of a significant number of manic/hypomanic items in patients with recurrent unipolar depression seems to challenge the traditional unipolar-bipolar dichotomy and bridge the gap between these two categories of mood disorders.
Medication effects in neuroimaging studies of bipolar disorder.
- M. Phillips, M. Travis, A. Fagiolini, D. Kupfer
- Psychology, MedicineThe American journal of psychiatry
- 1 March 2008
Neuroimaging studies of bipolar disorder ideally should recruit both unmedicated and medicated individuals, and individuals who are unable to tolerate medication withdrawal likely have more severe illness and are especially informative for research examining biomarkers of illness and treatment response.
Assessment and management of agitation in psychiatry: Expert consensus
- M. Garriga, I. Pacchiarotti, E. Vieta
- Medicine, PsychologyThe world journal of biological psychiatry : the…
- 17 February 2016
Recommendations on the assessment of agitation emphasise the importance of identifying any possible medical cause and the “ideal” medication should calm without over-sedate.
Anxiety as a correlate of response to the acute treatment of bipolar I disorder.
The findings suggest that anxiety is a clinically meaningful correlate of poor outcome in the acute treatment of bipolar I disorder.
Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States.
- B. Goldstein, A. Fagiolini, P. Houck, D. Kupfer
- Medicine, PsychologyBipolar disorders
- 1 September 2009
Adults with BD-I are at increased risk of CVD and HTN, prevalent over a decade earlier than non-BD adults, and strategies are needed to prevent excessive and premature cardiovascular burden in BD- I.
Prevalence of obesity and weight change during treatment in patients with bipolar I disorder.
The high prevalence of obesity in subjects with bipolar disorder emphasizes the need for specific treatment strategies and programs for weight control for these individuals.